Together, these findings suggest that USP20 and CTSL are closely linked to metastatic progression and poor clinical outcomes in hypopharyngeal carcinoma, highlighting their potential as prognostic biomarkers and therapeutic targets. The gene discussed is CTSL; the disease is hypopharyngeal carcinoma.